Hormonal activation of the p53 pathway at a critical time in mammary development in full-term pregnancy has been identified as one of the most critical determinants of long-term negative or positive alterations in the mammary gland influencing breast cancer risk. The gene discussed is TP53; the disease is breast carcinoma.